Programmed cell death 5 correlates with disease activity and interleukin-17 in serum and synovial fluid of rheumatoid arthritis patients
Authors:
- Jun-Feng WangJWJun-Feng Wang
- Zhen-Peng GuanZGZhen-Peng Guan
- Shao-Long ZhangSZShao-Long Zhang
- Zheng PeiZPZheng Pei
- Ying-Yu ChenYCYing-Yu Chen
- Huan PanHPHuan Pan
- 20 January 2013
- journal article
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 126 (2) , 296-299
Abstract
Background: Programmed cell death 5 (PDCD5) is a novel apoptotic regulatory gene that promotes apoptosis in various tumor cells. Studies have shown that PDCD5 accelerates the apoptosis of synoviocytes in vitro, implying a potential role in rheumatoid arthritis (RA) pathogenesis. This study examined the expression of PDCD5 in serum and synovial fluid of RA patients, its effect on the expression of inflammatory cytokine, interleukin-17 (IL-17), and the assessment of disease activity in RA. Methods: PDCD5 and IL-17 levels in serum and synovial fluid from 18 patients with RA and 22 patients with osteoarthritis (OA) were detected using enzyme-linked immunosorbent assay (ELISA). Concentrations of serum PDCD5 in 40 healthy people were also detected as controls. As disease activity indices, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), and X-ray grading scale were also evaluated. Results: Serum and synovial fluid PDCD5 levels in RA patients were significantly higher than those in OA and healthy controls. Serum PDCD5 level was inversely correlated to CRP and ESR, and was significantly higher in the RF negative group than in the positive group. PDCD5 level was also negatively correlated with IL-17 levels both in serum and synovial fluid of RA patients. However, differences in synovial fluid PDCD5 level from RA patients at different Larsen stages were not detectable. Conclusions: PDCD5 affects RA pathogenesis. Insufficient apoptosis of fibroblast-like synoviocytes and inflammatory cells in RA could increase the expression of PDCD5 protein. As PDCD5 levels correlated negatively with disease activity indices and IL-17 level, PDCD5 could become a target in the diagnosis and treatment of RA.Keywords
This publication has 13 references indexed in Scilit:
- Involvement of PDCD5 in the regulation of apoptosis in fibroblast-like synoviocytes of rheumatoid arthritisApoptosis, 2007
- Association of the PDCD5 Locus With Lung Cancer Risk and Prognosis in SmokersJournal of Clinical Oncology, 2006
- Two Single-Nucleotide Polymorphisms with Linkage Disequilibrium in the HumanProgrammed Cell Death 5Gene 5′ Regulatory Region Affect Promoter Activity and the Susceptibility of Chronic Myelogenous Leukemia in Chinese PopulationClinical Cancer Research, 2005
- Interferon Alfa Regulated Gene Expression in Patients Initiating Interferon Treatment for Chronic Hepatitis CHepatology, 2003
- Apoptosis as a therapeutic tool in rheumatoid arthritisNature Reviews Immunology, 2002
- Gene-Expression Profiles in Hereditary Breast CancerNew England Journal of Medicine, 2001
- TFAR19,a Novel Apoptosis-Related Gene Cloned from Human Leukemia Cell Line TF-1, Could Enhance Apoptosis of Some Tumor Cells Induced by Growth Factor WithdrawalBiochemical and Biophysical Research Communications, 1999
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986